Evidence map›Paper›PMID 34400625›Full record

ArticleNature communications2021

Electrophysiological engineering of heart-derived cells with calcium-dependent potassium channels improves cell therapy efficacy for cardioprotection.

Patrick Vigneault, Sandrine Parent, Pushpinder Kanda, Connor Michie, Darryl R Davis, Stanley Nattel

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Patrick Vigneault *Research Center and Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada.
Sandrine Parent *Division of Cardiology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Pushpinder KandaDivision of Cardiology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Connor MichieDivision of Cardiology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Darryl R DavisDivision of Cardiology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada. ddavis@ottawaheart.ca.ORCID 0000-0001-9642-3910
Stanley NattelResearch Center and Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada. stanley.nattel@icm-mhi.org.ORCID 0000-0002-5565-3311
University of Ottawa · CAMontreal Heart Institute · CA

Funding

CIHR 148401CIHR 162088
6 · The paper itself

Abstract

We have shown that calcium-activated potassium (KCa)-channels regulate fundamental progenitor-cell functions, including proliferation, but their contribution to cell-therapy effectiveness is unknown. Here, we test the participation of KCa-channels in human heart explant-derived cell (EDC) physiology and therapeutic potential. TRAM34-sensitive KCa3.1-channels, encoded by the KCNN4 gene, are exclusively expressed in therapeutically bioactive EDC subfractions and maintain a strongly polarized resting potential; whereas therapeutically inert EDCs lack KCa3.1 channels and exhibit depolarized resting potentials. Somatic gene transfer of KCNN4 results in membrane hyperpolarization and increases intracellular [Ca

Indexed as

Electrophysiological PhenomenaHeartAnimalsCalciumCell- and Tissue-Based TherapyCell ProliferationCytokinesGene Expression RegulationHumansIntermediate-Conductance Calcium-Activated Potassium ChannelsIschemiaMembrane PotentialsMiceMyocardiumNanoparticlesPotassiumCalciumCytokinesIntermediate-Conductance Calcium-Activated Potassium ChannelsKCNN4 protein, humanKcnn4 protein, mousePotassiumPotassium Channel BlockersPotassium Channels, Calcium-Activated

Identifiers

PMID34400625
PMCPMC8368210
OpenAlexW3193392203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.